Clinical Trial Update: A Pilot Trial of Rituxan in Refractory Myasthenia Gravis [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 1/2 pilot trial of rituximab (Rituxan) in patients with refractory myasthenia gravis. The study was sponsored by t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University of Vermont | Conditions: Refractory Myasthenia Gravis | Phase 1, Phase 2 | Status: COMPLETED